K252a and staurosporine microbial alkaloid toxins aS prototype of neurotropic drugs

Advances in Experimental Medicine and Biology

Volumn 391, Issue , 1996, Pages 367-377

  Lazarovici, Philip ^a   Rasouly, David ^a   Friedman, Lilach ^a   Tabekman, Rinat ^a   Ovadia, Haim ^b   Matsuda, Yuzuru ^c  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA;

CARBAZOLE DERIVATIVE; ENZYME INHIBITOR; K 252; PROTEIN KINASE C; STAUROSPORINE; BACTERIAL TOXIN; K 252A; NERVE GROWTH FACTOR; NEUROTROPIC AGENT; PROTEIN KINASE INHIBITOR;

ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; METABOLISM; MOUSE; NERVOUS SYSTEM; REVIEW; ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; ENZYME INHIBITION; HUMAN CELL; MULTIPLE SCLEROSIS; NERVE FIBER GROWTH; NEUROTROPISM; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; TOXIN ANALYSIS;

ANIMALS; CARBAZOLES; ENZYME INHIBITORS; HUMANS; MICE; NERVOUS SYSTEM; PROTEIN KINASE C; STAUROSPORINE;

EID: 0029665376     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4613-0361-9_31     Document Type: Article

References (32)

1. Albina, J.E., Abate, J.A., and Henry, W.L.Jr (1991). Nitric oxide production is required for murine resident peritoneal macrophages to supress mitogen stimulated T-cell proliferation. The American Association of Immunologists, 147, 144-148.
2. Ashall, F. and Goate, A.M. (1994), Role of the β-amyloid precursor protein in Alzheimer's disease. Trends in Biochem. Sci., 19, 42-45.
3. 252a inhibits nerve growth factor induced trk proto-oncogene tyrosine phosphorylation and kinase activity. J. Biol. Chem., 267, 13-16.
4. 4 amyloid protein precursor. Proc. Natl Acad. Sci. USA, 89, 10075-10078.
5. 4 amyloid precursor protein. Proc. Natl. Acad. Sci. USA, 89, 3055-3059.
6. Carrieri, P.B. (1994). The role of cytokines in the pathogenesis of multiple sclerosis. Int. Multiple Sclerosis, 1, 53-59.
7. Couchie, D., Mavilia, C., Georgieff, I.S., Lien, R.K.H., Shelanski, M.L. and Nunez, J. (1992). Primary structure of high molecular weight tau present in the peripheral nervous system. Proc. Natl. Acad. Sci. USA, 89, 4378-4381.
8. Denis, M. (1991). Interferon-gamma treated murine macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediates. Cellular Immunology, 132, 150-157.
9. Dyrks, T., Weidemann, A., Multhaup, G., Salbaum, J.M., Lemaire, H.G., Kang, J., Muller-Hill, B., Masters, C.L. and Beyreuther, K. (1988). Identification, transmembrane orientation and biogenesis of the amyloid A4 precursor of Alzheimer's disease. EMBO J., 7, 949-957.
10. Edelman, A.M., Blumenthal, D.K. and Krebs, E.G. (1987). Protein serine/threonine kinases. Ann. Rev. Biochem., 56, 567-613.
11. Hunter, T. (1991). Protein kinases classification. Methods Enzymol., 200, 3-38.
12. r) mice. Eur. J. Immunol., 21, 693-699.
13. Kaplan, D.R., Hempstead, B.L., Martin-Zanca, D., Chao, M.V. and Parada, L.F. (1991). The trk proto-oncogene product: a signal transduction receptor for nerve growth factor. Science, 252, 554-557.
14. Kikkawa, U. and Nishizuka, Y. (1986). The role of protein kinase C in transmembrane signaling. Ann. Rev. Cell. Biol., 2, 149-178.
15. 252a: a specific inhibitor of the action of nerve growth factor on PC12 cells. J. Neurosci., 8, 715-721.
16. 252a inhibits the increase in c-fos transcription and the increase in intracellular calcium produced by nerve growth factor in PC12 cells. J. Neurosci. Res., 23, 1-8.
17. Levi-Montalcini, R. (1987). The nerve growth factor: thirty-five years later. Science, 237, 1154-1164.
18. Matsuda, Y. (1993). Screening of bioactive substances of microbial origin based on enzyme and receptor binding assays. Actinomycetology, 7, 110-118.
19. McFarlin, D.E., Blank, S.E. and Kibler, R.F. (1974). Recurrent experimental allergic encephalomyelitis in the Lewis rats. J. Immunol., 113, 712-715.
20. Moncada, S., Palmer, R.M.J. and Higgs, E.A. (1991). Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev., 43, 109-136.
21. Nabeshima, T., Ogawa, S.I., Nishimura, H., Fuji, K., Kameyama, T. and Sasaki, Y. (1991). Staurosporine facilitates recovery from the basal forebrain-lesion-induced impairment of learning and deficit of cholinergic neurons in rats. J. Pharmacol. Exp. Therap., 257, 562-566.
22. Nairn, A.C., Hemmings, H.S. and Greengard, P. (1985). Protein kinases in the brain. Ann. Rev. Biochem., 54, 931-976.
23. Parker, P.J., Cook, P.P., Olivier, A.R., Pears, C, Ways, D.K. and Webster, C. (1992). Second messenger systems as pharmacological targets. Biochem. Soc. Trans., 20, 415-418.
24. Quarles, R.H., Morell, P. and McFarlin, D.E. (1989). Diseases involving myelin. In: Basic Neurochemistry (Siegel, G., Agranoff, G., Albeis, R.W. and Molinoff, P. eds.), 697-713, Raven press, New York.
25. Rasouly, D., Rahamim, E., Lester, D., Matsuda, Y. and Lazarovici, P. (1992). Staurosporine-induced neurite outgrowth in PC12 cells is independent of protein kinase C inhibition. Mol. Pharmacol., 42, 35-43.
26. Rasouly, D., Rahamim, E., Ringel, I., Ginzburg, I., Muarakata, C., Matsuda, Y. and Lazarovici, P. (1994). Neurites induced by staurosporine in PC12 cells are resistant to colchicine and express high levels of tau proteins. Mol. Pharmacol., 45, 29-35.
27. Rasouly, D. and Lazarovici, P. (1994). Staurosporine, a kinase inhibitor with neurotropic effects, induces the tyrosine phosphorylation of a 145 kD protein, but does not activate trk in PC12 cells. Europ. J. Pharmacol. - Mol. Sec., 269, 255-264.
28. 252 microbial alkaloids. In: The Toxic Action of Marine and Terrestrial Alkaloids (Blum, M.S. ed), pp. 161-190. Alaken Inc., Fort Collins, CO., USA.
29. Rasouly, D., Shavit D., Zuniga, R., Elejalde, R.B., Unsworth, B.R., Yayon, A., Lazarovici, P. and Lelkes, P.I. (1996). Staurosporine induces neurite outgrowth in neuronal hybrids (PC12EN) lacking NGF receptors. J. Cell. Biochem., in press.
30. Sadot, E., Barg, J., Rasouly, D., Lazarovici, P. and Ginzburg, I. (1995). Short-term and long-term mechanisms of tau regulation in PC12 cells. J. Cell Sci. 108, 2857-2864.
31. α. J. Biol. Chem, 268, 21097-21101.
32. Tamaoki, T. (1991). Use and specificity of staurosporine, UCN-01 and calphostin C as protein kinase inhibitors. Methods Enzymol., 201, 340-347.